Anti-inflammatory therapy with canakinumab for atherosclerotic disease: Lessons from the CANTOS trial

Peter L. Thompson, S. Mark Nidorf

Research output: Contribution to journalEditorial

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)695-698
Number of pages4
JournalJournal of Thoracic Disease
Volume10
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Cite this

@article{0b86f6a5790b49feb50a5dc77b8833a5,
title = "Anti-inflammatory therapy with canakinumab for atherosclerotic disease: Lessons from the CANTOS trial",
author = "Thompson, {Peter L.} and {Mark Nidorf}, S.",
year = "2018",
month = "2",
day = "1",
doi = "10.21037/jtd.2018.01.119",
language = "English",
volume = "10",
pages = "695--698",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
publisher = "AME PUBL CO",
number = "2",

}

Anti-inflammatory therapy with canakinumab for atherosclerotic disease : Lessons from the CANTOS trial. / Thompson, Peter L.; Mark Nidorf, S.

In: Journal of Thoracic Disease, Vol. 10, No. 2, 01.02.2018, p. 695-698.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Anti-inflammatory therapy with canakinumab for atherosclerotic disease

T2 - Lessons from the CANTOS trial

AU - Thompson, Peter L.

AU - Mark Nidorf, S.

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85042127293&partnerID=8YFLogxK

U2 - 10.21037/jtd.2018.01.119

DO - 10.21037/jtd.2018.01.119

M3 - Editorial

VL - 10

SP - 695

EP - 698

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

IS - 2

ER -